Hemp compound tested for spinal cord injury pain relief

NCT ID NCT05630235

Completed Symptom relief Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This small early-phase trial tests whether a single oral dose of a hemp-derived CBD/CBD-A extract can reduce neuropathic pain and change brain activity in people with spinal cord injury. Six participants with moderate to severe nerve pain for at least three months will receive either the extract or a placebo. The study measures pain intensity, unpleasantness, and brain electrical patterns using EEG.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hemp-derived cannabidiol (CBD) and cannabidiolic-acid (CBD-A) oral extract
What this could lead to: If it works, this could point toward a new option for managing chronic nerve pain after spinal cord injury.
What could go wrong: This is a very small, early-phase trial with only 6 participants, so results may not apply widely. The one-time dose may not reflect real-world use, and side effects are not yet well understood.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuralgia spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROPATHIC PAIN SCI - SPINAL CORD INJURY

Contacts and locations

Locations

Lynn Rehabilitation Center

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.